In addition, decreased YTHDF2 expression and increased IGF2BP2 expression were found in resistant ovarian cancer cells, which might be contributing to FZD10 upregulation for promoting cancer drug resistance (57). The gene discussed is FZD10; the disease is ovarian cancer.